Review: taking Coumadin and Alli together


Summary

Drug interactions are reported among people who take Coumadin and Alli together. This review analyzes the effectiveness and drug interactions between Coumadin and Alli. It is created by eHealthMe based on reports of 267 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Alli >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 73,270 users)

Alli

Alli has active ingredients of orlistat. It is often used in weight loss. (latest outcomes from Alli 16,975 users)

On Jul, 25, 2016

267 people who take Coumadin, Alli are studied.


Number of reports submitted per year:

Coumadin and Alli drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Alli:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Alli:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Alli:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • coagulopathy
  • international normalised ratio increased
  • chest pain
  • blood in stool
  • dizziness
  • haematochezia
  • haemorrhage
  • insomnia
  • malaise
  • rectal haemorrhage
1 - 6 months:
  • blood viscosity increased
  • chest discomfort
  • dyspnoea
  • ill-defined disorder
  • abdominal distension
  • abdominal pain
  • abdominal pain upper
  • anxiety
  • asthenia
  • back pain
6 - 12 months:
  • international normalised ratio decreased
  • international normalised ratio increased
not specified:
  • international normalised ratio increased
  • atrial fibrillation
  • blood glucose increased
  • fatigue
  • nausea
  • multiple injuries
  • cardiac failure congestive
  • cholecystitis acute
  • cardiomyopathy
  • palpitations

Most common drug interactions by gender *:

female:
  • international normalised ratio increased
  • atrial fibrillation
  • back pain
  • nausea
  • steatorrhoea
  • abdominal pain upper
  • cardiac failure congestive
  • influenza like illness
  • vomiting
  • dyspnoea
male:
  • international normalised ratio increased
  • atrial fibrillation
  • cholecystitis acute
  • blood glucose increased
  • fatigue
  • aortic valve calcification
  • cardiac failure
  • hypotension
  • mitral valve incompetence
  • multiple injuries

Most common drug interactions by age *:

20-29:
  • bronchitis
  • cardiac failure congestive
  • cholecystitis
  • influenza like illness
  • insomnia
  • urinary tract infection
  • atrial fibrillation
  • intracardiac thrombus
  • mass
  • multi-organ failure
30-39:
  • abdominal distension
  • anxiety
  • asthenia
  • back pain
  • dizziness
  • dyskinesia
  • dyspnoea
  • international normalised ratio decreased
  • irritability
  • muscular weakness
40-49:
  • cholecystitis acute
  • aortic valve calcification
  • atrial fibrillation
  • cardiac failure
  • mitral valve incompetence
  • blood glucose increased
  • exercise tolerance decreased
  • hepatojugular reflux
  • brain natriuretic peptide increased
  • cardiomyopathy
50-59:
  • international normalised ratio increased
  • abdominal distension
  • abdominal pain upper
  • fluid retention
  • diarrhoea
  • difficulty in walking
  • face oedema
  • large intestinal haemorrhage
  • lower gastrointestinal haemorrhage
  • mouth ulceration
60+:
  • international normalised ratio increased
  • atrial fibrillation
  • steatorrhoea
  • fatigue
  • nausea
  • coagulopathy
  • dyspnoea
  • myocardial infarction
  • weight increased
  • acute coronary syndrome

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Alli?

Can you answer these questions?

More questions for: Coumadin, Alli

You may be interested in these reviews

More reviews for: Coumadin, Alli

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Alli (orlistat) is often used to treat weight loss. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.